MedKoo Cat#: 128281 | Name: YW-N-7

Description:

WARNING: This product is for research use only, not for human or veterinary use.

YW-N-7 is a RET inhibitor. YW-N-7 exhibited dual action of selectively inhibiting and depleting RET protein both in vitro and in vivo. Proteomic analysis indicated that YW-N-7 is highly specific to RET. In cell cultures, reducing RET fusion protein potentiated the activity of LOXO-292. Furthermore, YW-N-7 showed significant activity in inhibiting KIF5B-RET-driven xenograft tumors in animals.

Chemical Structure

YW-N-7
YW-N-7
CAS#N/A

Theoretical Analysis

MedKoo Cat#: 128281

Name: YW-N-7

CAS#: N/A

Chemical Formula: C56H62N12O7

Exact Mass: 1014.4864

Molecular Weight: 1015.19

Elemental Analysis: C, 66.26; H, 6.16; N, 16.56; O, 11.03

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
YW-N-7; YW-N7; YWN-7; YW N 7
IUPAC/Chemical Name
6-(4-(8-((3-cyano-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridin-6-yl)oxy)octanoyl)piperazin-1-yl)-N-(2-(4-(2,6-dioxopiperidin-3-yl)phenoxy)ethyl)nicotinamide
InChi Key
MHUDDFDJRNFHOV-UHFFFAOYSA-N
InChi Code
InChI=1S/C56H62N12O7/c1-73-52-19-8-38(30-61-52)34-67-43-27-44(67)36-66(35-43)50-16-11-40(31-59-50)48-28-46(37-68-54(48)42(29-57)33-62-68)74-25-6-4-2-3-5-7-53(70)65-23-21-64(22-24-65)49-17-12-41(32-60-49)55(71)58-20-26-75-45-13-9-39(10-14-45)47-15-18-51(69)63-56(47)72/h8-14,16-17,19,28,30-33,37,43-44,47H,2-7,15,18,20-27,34-36H2,1H3,(H,58,71)(H,63,69,72)
SMILES Code
COC1=CC=C(C=N1)CN(C(C2)C3)C2CN3C4=CC=C(C=N4)C5=CC(OCCCCCCCC(N6CCN(C7=NC=C(C(NCCOC8=CC=C(C9C(NC(CC9)=O)=O)C=C8)=O)C=C7)CC6)=O)=CN%10N=CC(C#N)=C%105
Appearance
To be determined
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 -4 C for short term (days to weeks) or -20 C for long term(months to years).
Solubility
To be determined
Shelf Life
>2 years if stored properly
Drug Formulation
To be determined
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 1,015.19 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Wang Y, Hu X, Pandey S, Khatri U, Shen T, Subbiah V, Mooers BHM, Chao T, Wang S, Yu H, Sun X, Wu J, Cai J. Targeting Oncogenic RET Kinase by Simultaneously Inhibiting Kinase Activity and Degrading the Protein. J Med Chem. 2024 Dec 26. doi: 10.1021/acs.jmedchem.4c01424. Epub ahead of print. PMID: 39723919.